🇺🇸 FDA
Patent

US 7255850

Methods for measuring rates of reserve cholesterol transport in vivo, as an index of anti-atherogenesis

granted A61KA61K49/0004A61K51/04

Quick answer

US patent 7255850 (Methods for measuring rates of reserve cholesterol transport in vivo, as an index of anti-atherogenesis) held by The Regents of the University of California expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 14 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K49/0004, A61K51/04, A61K51/0493, A61K51/1224